NASDAQ:CRON Cronos Group (CRON) Stock Price, News & Analysis → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free CRON Stock Alerts $2.48 +0.01 (+0.40%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$2.43▼$2.5550-Day Range$1.93▼$2.8852-Week Range$1.64▼$2.99Volume2.52 million shsAverage Volume2.93 million shsMarket Capitalization$947.38 millionP/E RatioN/ADividend YieldN/APrice Target$2.83 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Cronos Group alerts: Email Address Cronos Group MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside14.2% Upside$2.83 Price TargetShort InterestHealthy2.79% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.67Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.01) to $0.03 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.72 out of 5 starsMedical Sector596th out of 909 stocksMedicinals & Botanicals Industry3rd out of 10 stocks 2.2 Analyst's Opinion Consensus RatingCronos Group has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCronos Group has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.79% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cronos Group has recently decreased by 13.82%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRON. Previous Next 3.2 News and Social Media Coverage News SentimentCronos Group has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cronos Group this week, compared to 2 articles on an average week.Search Interest16 people have searched for CRON on MarketBeat in the last 30 days. This is an increase of 45% compared to the previous 30 days.MarketBeat FollowsOnly 10 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.96% of the stock of Cronos Group is held by insiders.Percentage Held by InstitutionsOnly 8.71% of the stock of Cronos Group is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Cronos Group are expected to grow in the coming year, from ($0.01) to $0.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is -13.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is -13.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Cronos Group Stock (NASDAQ:CRON)Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Read More CRON Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRON Stock News HeadlinesApril 8, 2024 | marketbeat.comCannabis: One Stock to Play the Movement (CRON)With talk of decriminalizing marijuana once again becoming part of the national conversation, there's one cannabis ETF that may provide the best valueApril 23, 2024 | businesswire.comFresh Retail Software Industry Leader Invafresh Announces Appointment of Andrew Cron, PhD as Chief Data OfficerApril 24, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.April 21, 2024 | investorplace.com3 Speculative Penny Stocks That Can Spike to Double Digits in 2024April 16, 2024 | investorplace.com3 Cannabis Penny Stocks to Buy for 3-Bagger ReturnsApril 12, 2024 | investorplace.com7 Penny Stocks That Could Deliver 1,000% Returns by 2029April 9, 2024 | fool.comWhy Marijuana Stocks Got Burnt TodayApril 9, 2024 | msn.comCCH Pounder & ‘Selma’ Producer Paul Garnes To Attend First Cross Continental International Co-production Forum In BarbadosApril 24, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...April 9, 2024 | msn.com4 stocks to watch on Tuesday: GE, TSM and moreApril 8, 2024 | msn.comWhat's behind Russian frenzy to blame Ukraine for concert attack?April 8, 2024 | fool.comWhy Canopy Growth, Cronos, and Aurora Cannabis Stocks Popped on MondayApril 8, 2024 | markets.businessinsider.comCautious Outlook on Cronos Group Amid Slow Regulatory Progress in Cannabis IndustryApril 4, 2024 | investorplace.comThe 3 Best Meme Stocks to Buy in April 2024April 3, 2024 | msn.comWhy Canadian Marijuana Stocks Popped TodayApril 3, 2024 | fool.comWhy Canadian Marijuana Stocks Popped TodayMarch 29, 2024 | investorplace.com7 High-Potential Penny Stocks to Buy for Massive ROIMarch 28, 2024 | investorplace.comThe 3 Best Cannabis Stocks to Buy in Q2 2024March 28, 2024 | investorplace.comThe 3 Best Meme Stocks to Buy in Q2 2024March 26, 2024 | fool.comWhy Marijuana Stocks Are Hopping Again on TuesdayMarch 26, 2024 | investorplace.com3 Cannabis Stocks That Could Be Multibaggers in the Making: March EditionMarch 25, 2024 | investorplace.comGo Contrarian: 3 Analyst ‘Sells' That Could Be Buys in DisguiseMarch 25, 2024 | globenewswire.comCronos Launches Lord Jones® Chocolate FusionsMarch 22, 2024 | investorplace.comDear Cannabis Stocks Fans, Mark Your Calendars for April 1March 22, 2024 | fool.comWhy Tilray, Cronos, and Canopy Growth Stocks All Popped TodayMarch 18, 2024 | seekingalpha.comCronos Group Inc. (CRON) Roth MKM 36th Annual ROTH Conference (Transcript)March 18, 2024 | seekingalpha.comAltria: Still Undervalued, Buy On StrengthSee More Headlines Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/29/2024Today4/24/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolNASDAQ:CRON CUSIPN/A CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees356Year FoundedN/APrice Target and Rating Average Stock Price Target$2.83 High Stock Price Target$3.00 Low Stock Price Target$2.50 Potential Upside/Downside+14.2%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,960,000.00 Net Margins-84.15% Pretax Margin-84.44% Return on Equity-3.99% Return on Assets-3.87% Debt Debt-to-Equity RatioN/A Current Ratio22.54 Quick Ratio21.81 Sales & Book Value Annual Sales$87.24 million Price / Sales10.86 Cash FlowN/A Price / Cash FlowN/A Book Value$2.87 per share Price / Book0.86Miscellaneous Outstanding Shares382,010,000Free Float374,524,000Market Cap$947.38 million OptionableOptionable Beta1.17 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Michael Ryan Gorenstein J.D. (Age 37)President, CEO & Chairman Comp: $3.94MMr. James Holm (Age 41)Chief Financial Officer Comp: $314.31kMr. Jeffrey David Jacobson (Age 38)Chief Growth Officer Comp: $730.12kMs. Anna Shlimak (Age 38)Senior Vice President of Corporate Affairs & Strategy Comp: $530.5kMr. James Andrew McGinness III (Age 45)VP, Controller & Principal Accounting Officer Mr. Shayne J. LaidlawDirector of Investor Relations & StrategyMr. Terry Gregory-Joseph Doucet (Age 34)General Counsel & Corporate Secretary Ms. Shannon Buggy (Age 54)Senior VP & Global Head of People Comp: $438.81kMr. Arye Weigensberg (Age 41)Senior VP & Head of Research and Development More ExecutivesKey CompetitorsUSANA Health SciencesNYSE:USNACanopy GrowthNASDAQ:CGCMind Medicine (MindMed)NASDAQ:MNMDbioteNASDAQ:BTMDAurora CannabisNASDAQ:ACBView All CompetitorsInsiders & InstitutionsRevisor Wealth Management LLCBought 19,446 shares on 4/23/2024Ownership: 0.005%Madrona Financial Services LLCBought 50,000 shares on 4/19/2024Ownership: 0.013%SeaCrest Wealth Management LLCBought 19,000 shares on 4/18/2024Ownership: 0.018%IMC Chicago LLCBought 150,900 shares on 4/13/2024Ownership: 0.000%AdvisorShares Investments LLCBought 353,404 shares on 2/14/2024Ownership: 0.129%View All Insider TransactionsView All Institutional Transactions CRON Stock Analysis - Frequently Asked Questions Should I buy or sell Cronos Group stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRON shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares. View CRON analyst ratings or view top-rated stocks. What is Cronos Group's stock price target for 2024? 3 Wall Street research analysts have issued 12-month price objectives for Cronos Group's stock. Their CRON share price targets range from $2.50 to $3.00. On average, they expect the company's stock price to reach $2.83 in the next year. This suggests a possible upside of 14.2% from the stock's current price. View analysts price targets for CRON or view top-rated stocks among Wall Street analysts. How have CRON shares performed in 2024? Cronos Group's stock was trading at $2.09 at the start of the year. Since then, CRON shares have increased by 18.7% and is now trading at $2.48. View the best growth stocks for 2024 here. Are investors shorting Cronos Group? Cronos Group saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 5,550,000 shares, a decline of 13.8% from the March 15th total of 6,440,000 shares. Based on an average daily volume of 2,860,000 shares, the short-interest ratio is presently 1.9 days. Approximately 2.8% of the company's shares are sold short. View Cronos Group's Short Interest. When is Cronos Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our CRON earnings forecast. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) posted its earnings results on Thursday, February, 29th. The company reported ($0.05) earnings per share for the quarter. The business earned $23.92 million during the quarter, compared to the consensus estimate of $25.15 million. Cronos Group had a negative net margin of 84.15% and a negative trailing twelve-month return on equity of 3.99%. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and Organigram (OGI). Who are Cronos Group's major shareholders? Cronos Group's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include IMC Chicago LLC (0.00%), SeaCrest Wealth Management LLC (0.02%), Madrona Financial Services LLC (0.01%) and Revisor Wealth Management LLC (0.01%). View institutional ownership trends. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CRON) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
